On December 31, 2024, Francis Duhay, a Director at enVVeno Medical Corp (NVNO, Financial), purchased 81,433 shares of the company. Following this transaction, the insider now holds a total of 102,344 shares. The transaction details can be found in the SEC Filing.
enVVeno Medical Corp is a company focused on the development of innovative medical devices. The company aims to address unmet needs in the treatment of venous disease, providing solutions that improve patient outcomes.
The recent purchase by Francis Duhay is part of a broader trend of insider activity within the company. Over the past year, there have been five insider buys and one insider sell. This indicates a general trend of insider confidence in the company's prospects.
Shares of enVVeno Medical Corp were trading at $3.07 each on the day of the insider's purchase, resulting in a market cap of $58.921 million. The company's valuation metrics, such as the GF Value, price-earnings ratio, price-sales ratio, price-book ratio, and price-to-free cash flow, provide further insights into the stock's current market position.
The insider's recent acquisition of shares reflects a significant increase in personal investment in the company, which may be interpreted as a positive signal to the market.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
